1
|
Zhang P, Tan J, Lin Y, Zhang H, Deng G, Chen X. Linezolid for patients with multidrug-resistant tuberculosis/extensively drug-resistant tuberculosis in China. Drug Discov Ther 2022; 16:96-98. [PMID: 35444071 DOI: 10.5582/ddt.2022.01024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Linezolid has been one of the key anti-tuberculosis agents for the treatment of multidrug-resistant tuberculosis (MDR-TB)/extensively drug-resistant tuberculosis (XDR-TB). It used to be very expensive and was not covered by social insurance from local governments. Nevertheless, a growing number of patients in China received linezolid in their anti- MDR/XDR TB regimens over the past decade. Many scholars in China have reported their experience using linezolid to treat patients with MDR/XDR-TB. In view of this, existing evidence of the efficacy and safety of linezolid and problems faced by Chinese patients with MDR/XDR-TB are summarized here.
Collapse
Affiliation(s)
- Peize Zhang
- Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China.,Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
| | - Jie Tan
- Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China
| | - Yi Lin
- Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China
| | - Hailin Zhang
- Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China
| | - Guofang Deng
- Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China
| | - Xiaoyou Chen
- Beijing Tuberculosis and Thoracic Tumor Institute, Beijing, China
| |
Collapse
|
2
|
Lv H, Xiao Z, Zhai S, Hao J, Tong Y, Wang G, An Q. Construction of nickel ferrite nanoparticle-loaded on carboxymethyl cellulose-derived porous carbon for efficient pseudocapacitive energy storage. J Colloid Interface Sci 2022; 622:327-335. [PMID: 35525136 DOI: 10.1016/j.jcis.2022.04.133] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2022] [Revised: 04/22/2022] [Accepted: 04/23/2022] [Indexed: 12/14/2022]
Abstract
The preparation of biomass-derived carbon electrode materials with abundant active sites is suitable for development of energy-storage systems with high energy and power densities. Herein, a hybrid material consisting of highly-dispersed nickel ferrite nanoparticle on 3D hierarchical carboxymethyl cellulose-derived porous carbon (NiFe2O4/CPC) was prepared by simple annealing treatment. The synergistic effects of NiFe2O4 species with multiple oxidation states and 3D porous carbon with a large specific surface area offered abundant active centers, fast electron/ion transport, and robust structural stability, thereby showing the excellent performance of the electrochemical capacitor. The best performing sample (NiFe2O4/CPC-800) exhibited a superior capacitance of 2894F g-1 at a current density of 0.5 A g-1. Encouragingly, an asymmetric supercapacitor with NiFe2O4/CPC-800 as a positive electrode and activated carbon as a negative electrode delivered a high energy density of 135.2 W h kg-1 along with an improved power density of 10.04 kW kg-1. Meanwhile, the superior cycling stability of 90.2% over 10,000 cycles at 5 A g-1 was achieved. Overall, the presented work offers a guideline for the design and preparation of advanced electrode materials for energy-storage systems.
Collapse
Affiliation(s)
- Hui Lv
- Liaoning Key Lab of Lignocellulose Chemistry and Biomaterials, Liaoning Collaborative Innovation Center for Lignocellulosic Biorefinery, College of Light Industry and Chemical Engineering, Dalian Polytechnic University, Dalian 116034, China
| | - Zuoyi Xiao
- Liaoning Key Lab of Lignocellulose Chemistry and Biomaterials, Liaoning Collaborative Innovation Center for Lignocellulosic Biorefinery, College of Light Industry and Chemical Engineering, Dalian Polytechnic University, Dalian 116034, China.
| | - Shangru Zhai
- Liaoning Key Lab of Lignocellulose Chemistry and Biomaterials, Liaoning Collaborative Innovation Center for Lignocellulosic Biorefinery, College of Light Industry and Chemical Engineering, Dalian Polytechnic University, Dalian 116034, China
| | - Jingai Hao
- Liaoning Key Lab of Lignocellulose Chemistry and Biomaterials, Liaoning Collaborative Innovation Center for Lignocellulosic Biorefinery, College of Light Industry and Chemical Engineering, Dalian Polytechnic University, Dalian 116034, China
| | - Yao Tong
- Liaoning Key Lab of Lignocellulose Chemistry and Biomaterials, Liaoning Collaborative Innovation Center for Lignocellulosic Biorefinery, College of Light Industry and Chemical Engineering, Dalian Polytechnic University, Dalian 116034, China
| | - Guoxiang Wang
- Liaoning Key Lab of Lignocellulose Chemistry and Biomaterials, Liaoning Collaborative Innovation Center for Lignocellulosic Biorefinery, College of Light Industry and Chemical Engineering, Dalian Polytechnic University, Dalian 116034, China
| | - Qingda An
- Liaoning Key Lab of Lignocellulose Chemistry and Biomaterials, Liaoning Collaborative Innovation Center for Lignocellulosic Biorefinery, College of Light Industry and Chemical Engineering, Dalian Polytechnic University, Dalian 116034, China.
| |
Collapse
|